Tyra

Tyra targets large opportunities in FGFR biology, with clinical-stage programs in targeted oncology and genetically defined conditions.

Domain
Healthcare
Status
IPO’d/​Acquired
IPO Date
2021
Stage of Initial Investment
Series A
Initial Investment Year
2020
Tyra Hover Image